JWN
53
5
MPC
44
3
CAG
40
4
FOXA
52
-4
CHD
53
3
WY
59
-5
ES
26
-3
PVH
70
6
OKE
71
-6
DOV
65
-3
JNPR
47
-3
NTRS
57
-3
MTB
63
-2
HIG
68
-7
AMAT
48
6
BAC
50
-6
DHR
50
7
EW
37
-4
ADP
66
-3
MCO
80
-3
JWN
53
5
MPC
44
3
CAG
40
4
FOXA
52
-4
CHD
53
3
WY
59
-5
ES
26
-3
PVH
70
6
OKE
71
-6
DOV
65
-3
JNPR
47
-3
NTRS
57
-3
MTB
63
-2
HIG
68
-7
AMAT
48
6
BAC
50
-6
DHR
50
7
EW
37
-4
ADP
66
-3
MCO
80
-3
Financhill
Back

NovoCure Stock Predictions

Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
82

NVCR
NovoCure

Last Price:
30.52
Seasonality Move:
2.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 41.2% based on the past 9 years of stock performance.
  • NovoCure has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $29.85. The Score for NVCR is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 41.2% based on the past 9 years of stock performance.

NovoCure Stock Rating

Buy
82
NovoCure (NVCR) is a Buy

Is NovoCure overpriced?

  • NovoCure has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
32.60
52-Week Low:
11.66

Prediction Charts

Market Cap:
3.23B
Price in USD:
29.85
Volume:
12.15M
Beta:
1.13

Technical Analysis

SMA50:
16.86
SMA100:
17.73
SMA200:
17.27
52-Wk Change:
138.8%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 29.85 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 17.97 17.89 18.24 17.58
Nov-14 17.74 16.57 18.17 16.43
Nov-15 16.67 16.11 16.80 16.09
Nov-18 15.99 15.73 16.16 15.64
Nov-19 15.54 16.48 16.55 15.35
Nov-20 16.26 16.86 17.35 16.22
Nov-21 16.97 17.09 17.22 16.30
Nov-22 17.20 17.73 17.89 17.10
Nov-25 18.16 18.78 18.98 18.04
Nov-26 18.69 17.88 18.74 17.46
Nov-27 18.29 19.69 19.77 18.00
Nov-29 19.81 20.04 20.24 19.58
Dec-2 28.25 29.85 31.57 25.00
Dec-3 29.15 30.51 32.60 29.05

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.